161 related articles for article (PubMed ID: 37237078)
1. Genetic separation of chronic myeloid leukemia stem cells from normal hematopoietic stem cells at single-cell resolution.
Chen Y; Möbius S; Riege K; Hoffmann S; Hochhaus A; Ernst T; Rudolph KL
Leukemia; 2023 Jul; 37(7):1561-1566. PubMed ID: 37237078
[No Abstract] [Full Text] [Related]
2. Hematopoietic and Chronic Myeloid Leukemia Stem Cells: Multi-Stability versus Lineage Restriction.
Brown G
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362357
[TBL] [Abstract][Full Text] [Related]
3. Stem cells in chronic myelogenous leukemia.
Verfaillie CM
Hematol Oncol Clin North Am; 1997 Dec; 11(6):1079-114. PubMed ID: 9443047
[TBL] [Abstract][Full Text] [Related]
4. Exciting times for our field and the Journal.
Humphries RK
Exp Hematol; 2011 Mar; 39(3):271. PubMed ID: 21277347
[No Abstract] [Full Text] [Related]
5. Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition.
Bütow M; Testaquadra FJ; Baumeister J; Maié T; Chatain N; Jaquet T; Tillmann S; Crysandt M; Costa IG; Brümmendorf TH; Schemionek M
Haematologica; 2023 Apr; 108(4):1179-1185. PubMed ID: 36453102
[No Abstract] [Full Text] [Related]
6. Chronic versus acute myelogenous leukemia: a question of self-renewal.
Jamieson CH; Weissman IL; Passegué E
Cancer Cell; 2004 Dec; 6(6):531-3. PubMed ID: 15607956
[TBL] [Abstract][Full Text] [Related]
7. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.
Koschmieder S; Göttgens B; Zhang P; Iwasaki-Arai J; Akashi K; Kutok JL; Dayaram T; Geary K; Green AR; Tenen DG; Huettner CS
Blood; 2005 Jan; 105(1):324-34. PubMed ID: 15331442
[TBL] [Abstract][Full Text] [Related]
8. Association of KIR2DS4 and its variant KIR1D with leukemia.
Giebel S; Nowak I; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Kyrcz-Krzemien S; Kusnierczyk P
Leukemia; 2008 Nov; 22(11):2129-30; discussion 2130-1. PubMed ID: 18463675
[No Abstract] [Full Text] [Related]
9. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
Akashi K; Taniguchi S; Nagafuji K; Harada M; Shibuya T; Hayashi S; Gondo H; Niho Y
Leuk Res; 1993 Jul; 17(7):549-55. PubMed ID: 8326735
[TBL] [Abstract][Full Text] [Related]
10. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
[TBL] [Abstract][Full Text] [Related]
11. Chronic myelogenous leukemia: molecular and cellular aspects.
Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
[TBL] [Abstract][Full Text] [Related]
12. BCR-ABL expression in different subpopulations of functionally characterized Ph+ CD34+ cells from patients with chronic myeloid leukemia.
Maguer-Satta V; Petzer AL; Eaves AC; Eaves CJ
Blood; 1996 Sep; 88(5):1796-804. PubMed ID: 8781437
[TBL] [Abstract][Full Text] [Related]
13. Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells.
Li L; Bhatia R
Curr Opin Hematol; 2015 Jul; 22(4):324-9. PubMed ID: 26049753
[TBL] [Abstract][Full Text] [Related]
14. Separating the wheat from the chaff: selection of benign hematopoietic cells in chronic myeloid leukemia.
Dunbar CE; Stewart FM
Blood; 1992 Mar; 79(5):1107-10. PubMed ID: 1536939
[No Abstract] [Full Text] [Related]
15. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
[TBL] [Abstract][Full Text] [Related]
16. BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells.
Schemionek M; Elling C; Steidl U; Bäumer N; Hamilton A; Spieker T; Göthert JR; Stehling M; Wagers A; Huettner CS; Tenen DG; Tickenbrock L; Berdel WE; Serve H; Holyoake TL; Müller-Tidow C; Koschmieder S
Blood; 2010 Apr; 115(16):3185-95. PubMed ID: 20053753
[TBL] [Abstract][Full Text] [Related]
17. BCR/ABL rearrangement and leukemia phenotype.
Saglio G; Pane F; Martinelli G; Guerrasio A
Leukemia; 1999 Apr; 13 Suppl 1():S96. PubMed ID: 10232378
[No Abstract] [Full Text] [Related]
18. Methylenetetrahydrofolate reductase gene polymorphisms contribute to acute myeloid leukemia and chronic myeloid leukemia susceptibilities: appraisal of a recent meta-analysis.
Wang F; Sun G
Cancer Epidemiol; 2014 Dec; 38(6):773-4. PubMed ID: 25455654
[No Abstract] [Full Text] [Related]
19. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
Kelliher MA; McLaughlin J; Witte ON; Rosenberg N
Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6649-53. PubMed ID: 2204061
[TBL] [Abstract][Full Text] [Related]
20. Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia.
Pieroni F; Oliveira FM; Panepucci RA; Voltarelli JC; Simões BP; Falcão RP
Bone Marrow Transplant; 2006 Apr; 37(8):801-2. PubMed ID: 16501585
[No Abstract] [Full Text] [Related]
[Next] [New Search]